These findings were corroborated in the dementia stage (cohort-2) where serum BD-tau, but not t-tau, concentrations were significantly higher in A+/N+ individuals with dementia as compared with the A-/N- CN (p < 0.001, Fig. 1 and Supplementary Table 2). The gene discussed is MAPT; the disease is dementia.